A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer

被引：46

作者：

Nanda, Rita ^{[1
]}

Chow, Laura Q. ^{[2
]}

Dees, E. Claire ^{[3
]}

Berger, Raanan ^{[4
]}

Gupta, Shilpa ^{[5
]}

Geva, Ravit ^{[6
]}

Pusztai, Lajos ^{[7
]}

Dolled-Filhart, Marisa ^{[8
]}

Emancipator, Kenneth ^{[8
]}

Gonzalez, Edward J. ^{[8
]}

Houp, Jennifer ^{[8
]}

Pathiraja, Kumudu ^{[8
]}

Karantza, Vassiliki ^{[8
]}

Iannone, Robert ^{[8
]}

Gause, Christine K. ^{[8
]}

Cheng, Johnathan D. ^{[8
]}

Buisseret, Laurence ^{[9
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[4] Chaim Sheba Med Ctr, Tel Hashomer, Israel

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

[7] Yale Univ, Sch Med, New Haven, CT 06520 USA

[8] Merck & Co Inc, New York, NY USA

[9] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS14-S1-09

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

S1-09

引用

页数：2